CytoSorbents Corporation (CTSO)

[B52T38]

Question, Bertha: So from the Baxter announcement (thanks, btw), it looks like Oxiris is being used to treat sepsis, but they are running clinical studies in Italy. So can we therefore assume that Oxiris has not been FDA approved for sepsis yet?

And assuming that their trials go well, would a company like Baxter be able to immediately fund a big multi-million dollar US trial to get FDA approval, something that could beat CTSO to the FDA finish line?

Just wondering. Because if the basic technology of these kinds of filters works, I can see a whole lot of other Baxter-like companies jumping in...so I hope our patents will give us sufficent protection and longevity.

Thoughts?